0001955319-26-000001.txt : 20260327 0001955319-26-000001.hdr.sgml : 20260327 20260327152142 ACCESSION NUMBER: 0001955319-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260327 DATE AS OF CHANGE: 20260327 EFFECTIVENESS DATE: 20260327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nexo Therapeutics, Inc. CENTRAL INDEX KEY: 0001955319 ORGANIZATION NAME: EIN: 883136741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-465438 FILM NUMBER: 26806768 BUSINESS ADDRESS: STREET 1: 11757 W. KEN CARYL AVENUE STREET 2: SUITE F, 520 CITY: LITTLETON STATE: CO ZIP: 80127-3719 BUSINESS PHONE: 303-868-6790 MAIL ADDRESS: STREET 1: 11757 W. KEN CARYL AVENUE STREET 2: SUITE F, 520 CITY: LITTLETON STATE: CO ZIP: 80127-3719 D/A 1 primary_doc.xml X0708 D/A LIVE 0001955319 Nexo Therapeutics, Inc. 11757 W. KEN CARYL AVENUE SUITE F, 520 LITTLETON CO COLORADO 80127-3719 303-868-6790 DELAWARE None None Corporation true 2022 Andrew Phillips 11757 W. Ken Caryl Avenue Suite F, 520 Littleton CO COLORADO 80127-3719 Executive Officer Director Ali Behbahani 11757 W. Ken Caryl Avenue Suite F, 520 Littleton CO COLORADO 80127-3719 Director Carlo Rizzuto 11757 W. Ken Caryl Avenue Suite F, 520 Littleton CO COLORADO 80127-3719 Director Biotechnology Decline to Disclose 06b true 0001955319-25-000002 2022-11-15 false true true false 0 60000000 60000000 0 false 7 0 0 0 false Nexo Therapeutics, Inc. /s/ Andrew Phillips Andrew Phillips President 2026-03-27